Kline Ashley Hartmann has filed 3 insider transactions across 1 company since May 2025.
Most recent transaction: a grant/award of 38517 shares of PALVELLA THERAPEUTICS, INC. ($PVLA) on February 05, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 5, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Kline Ashley Hartmann | Chief Commercial Officer | A | Stock Option (Right to Buy) | 38517 | $0.00 | 38,517.0000 | 11,836,490 | 9999.99% | 0.33% |
| May 27, 2025 | PALVELLA THERAPEUTICS, INC. | $PVLA | Kline Ashley Hartmann | Chief Commercial Officer | A | Incentive Stock Option (right to buy) | 17436 | $0.00 | 17,436.0000 | 11,018,747 | 9999.99% | 0.16% |
| May 27, 2025 | PALVELLA THERAPEUTICS, INC. | $PVLA | Kline Ashley Hartmann | Chief Commercial Officer | A | Non-Qualified Stock Option (right to buy) | 111496 | $0.00 | 111,496.0000 | 11,018,747 | 9999.99% | 1.01% |